87 related articles for article (PubMed ID: 9275691)
1. [Preoperative intraluminal 5-FU osmosis chemotherapy as an adjuvant to radical resection for rectal cancer].
Lu J; Zhao L; Liu L
Zhonghua Wai Ke Za Zhi; 1996 Jan; 34(1):54-6. PubMed ID: 9275691
[TBL] [Abstract][Full Text] [Related]
2. [Reevaluation of intraluminal fluorouracil chemotherapy as an adjuvant to radical resection of colorectal cancer--results of a randomized trial].
Wan DS
Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):388-91. PubMed ID: 2854781
[TBL] [Abstract][Full Text] [Related]
3. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
[TBL] [Abstract][Full Text] [Related]
4. [Therapy results of locoregional recurrences in rectal cancer].
Böhm B; Helfritzsch H; Thiele M; Altendorf-Hofmann A; Scheele J
Zentralbl Chir; 2001 Aug; 126(8):596-601. PubMed ID: 11518998
[TBL] [Abstract][Full Text] [Related]
5. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
6. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of postoperative adjuvant chemotherapy for colorectal cancer].
Nozoe Y; Ogata Y; Miyagi Y; Nakagawa M; Matono K; Sasatomi T; Araki Y; Shirouzu K
Gan To Kagaku Ryoho; 2002 Jan; 29(1):67-72. PubMed ID: 11816480
[TBL] [Abstract][Full Text] [Related]
8. [Comparing the effect of adjuvant chemotherapy by portal vein infusion with intraluminal chemotherapy for colorectal cancer].
Pan ZZ; Wan DS; Lu ZH; Li LR; Chen G; Zhou ZW; Wu XJ; Ding PR; Wang FL
Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(15):918-21. PubMed ID: 15363253
[TBL] [Abstract][Full Text] [Related]
9. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
Taal BG; Van Tinteren H; Zoetmulder FA;
Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
[TBL] [Abstract][Full Text] [Related]
11. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
[TBL] [Abstract][Full Text] [Related]
12. [Preoperative intra-arterial chemotherapy for progressive lower rectal cancer].
Tang YQ; Tan ZM; Wang JK; Tang RJ; Wang J; Zhao HY; Mai C; Zhang XL; Cui SZ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1247-8. PubMed ID: 18676275
[TBL] [Abstract][Full Text] [Related]
13. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group.
Tveit KM; Guldvog I; Hagen S; Trondsen E; Harbitz T; Nygaard K; Nilsen JB; Wist E; Hannisdal E
Br J Surg; 1997 Aug; 84(8):1130-5. PubMed ID: 9278661
[TBL] [Abstract][Full Text] [Related]
15. [Combination of radiation, chemotherapy and surgery in rectal cancer--an analysis of 128 patients].
Wang ZY; Xu YC; Sun YZ; Li Y; Cui SZ; Chen W; Cui SR; Zhang DZ; Ding L
Zhonghua Zhong Liu Za Zhi; 1986 May; 8(3):228-30. PubMed ID: 3017666
[TBL] [Abstract][Full Text] [Related]
16. [Study of prophylactic intra-iliac and hepatic arterial infusion chemotherapy against pelvic recurrence and liver metastasis after radical resection for rectal cancer].
Tu SL; Yuan JH; Deng GL; Zhao ZS; Hu TY; Dong QJ; Cao HF; Ye ZY
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Mar; 10(2):149-52. PubMed ID: 17380456
[TBL] [Abstract][Full Text] [Related]
17. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
[TBL] [Abstract][Full Text] [Related]
18. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
[TBL] [Abstract][Full Text] [Related]
19. Differences in toxicity across gender in patients treated with chemoradiation for rectal cancer.
Kaminski A; Joseph D; Elsaleh H
Australas Radiol; 2007 Jun; 51(3):283-8. PubMed ID: 17504322
[TBL] [Abstract][Full Text] [Related]
20. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
